Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
Nature Communications 8: Article number: 15987 (2017); Published: 11 July 2017; Updated: 13 March 2018 In the original version of this Article, financial support was not fully acknowledged. The PDF and HTML versions of the Article have now been corrected to include the following: ‘This work was supp...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2018-03-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/ncomms16187 |
| _version_ | 1830177760347160576 |
|---|---|
| author | Peter J. Cook Rozario Thomas Ram Kannan Esther Sanchez de Leon Alexander Drilon Marc K. Rosenblum Maurizio Scaltriti Robert Benezra Andrea Ventura |
| author_facet | Peter J. Cook Rozario Thomas Ram Kannan Esther Sanchez de Leon Alexander Drilon Marc K. Rosenblum Maurizio Scaltriti Robert Benezra Andrea Ventura |
| author_sort | Peter J. Cook |
| collection | DOAJ |
| description | Nature Communications 8: Article number: 15987 (2017); Published: 11 July 2017; Updated: 13 March 2018 In the original version of this Article, financial support was not fully acknowledged. The PDF and HTML versions of the Article have now been corrected to include the following: ‘This work was supported by grant I10-0095 from the STARR foundation. |
| first_indexed | 2024-12-17T19:29:45Z |
| format | Article |
| id | doaj.art-e3bc39779c1940f3b63041d39757508e |
| institution | Directory Open Access Journal |
| issn | 2041-1723 |
| language | English |
| last_indexed | 2024-12-17T19:29:45Z |
| publishDate | 2018-03-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Nature Communications |
| spelling | doaj.art-e3bc39779c1940f3b63041d39757508e2022-12-21T21:35:17ZengNature PortfolioNature Communications2041-17232018-03-01911110.1038/ncomms16187Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic targetPeter J. CookRozario ThomasRam KannanEsther Sanchez de LeonAlexander DrilonMarc K. RosenblumMaurizio ScaltritiRobert BenezraAndrea VenturaNature Communications 8: Article number: 15987 (2017); Published: 11 July 2017; Updated: 13 March 2018 In the original version of this Article, financial support was not fully acknowledged. The PDF and HTML versions of the Article have now been corrected to include the following: ‘This work was supported by grant I10-0095 from the STARR foundation.https://doi.org/10.1038/ncomms16187 |
| spellingShingle | Peter J. Cook Rozario Thomas Ram Kannan Esther Sanchez de Leon Alexander Drilon Marc K. Rosenblum Maurizio Scaltriti Robert Benezra Andrea Ventura Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target Nature Communications |
| title | Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title_full | Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title_fullStr | Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title_full_unstemmed | Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title_short | Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target |
| title_sort | correction author correction somatic chromosomal engineering identifies bcan ntrk1 as a potent glioma driver and therapeutic target |
| url | https://doi.org/10.1038/ncomms16187 |
| work_keys_str_mv | AT peterjcook correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT rozariothomas correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT ramkannan correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT esthersanchezdeleon correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT alexanderdrilon correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT marckrosenblum correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT maurizioscaltriti correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT robertbenezra correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT andreaventura correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget |